REBECCA SIMMEL: Open Payments
NPI 1851071856 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,855 in 99 payments from 19 companies in 2025. Trend: 2023 $227 · 2024 $1,943 · 2025 $1,855
Food & beverage: $1,855
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $346 |
| GlaxoSmithKline, LLC. | 22 | $265 |
| CSL Behring | 14 | $263 |
| Regeneron Healthcare Solutions, Inc. | 10 | $226 |
| Novartis Pharmaceuticals Corporation | 10 | $189 |
| GENZYME CORPORATION | 6 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $109 |
| Cycle Pharmaceuticals Inc | 2 | $46 |
| Pharming Healthcare, Inc. | 2 | $45 |
| Genentech USA, Inc. | 2 | $35 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, Hizentra, TRELEGY ELLIPTA, CUVITRU, XOLAIR, Rhapsido.
Industry payments across KY — which companies pay providers there.
